Multiple gene approaches to delineate the role of the renin-angiotensin- aldosterone system in nephropathy

Journal of Hypertension

Volumn 23, Issue 2, 2005, Pages 269-272

  Michel, Martin C ^a,c   Hahntow, Ines ^b   Koopmans, Richard P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHRONIC DISEASE; DIABETIC NEPHROPATHY; EDITORIAL; GENETIC POLYMORPHISM; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MULTIGENE FAMILY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 14044273040     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200502000-00006     Document Type: Editorial

References (61)

1. Guyton AC. Blood pressure control - special role of the kidneys and body fluids. Science 1991; 252:1813-1816.
2. Romero JC, Knox FG. Mechanisms underlying pressure-related natriuresis: the role of the renin-angiotensin and prostaglandin systems. State of the art lecture. Hypertension 1988; 11:724-738.
3. Firth JD, Raine AEG, Ledingham JGG. The mechanism of pressure natriuresis. J Hypertens 1990; 8:97-103.
4. Roman RJ, Cowley AW Jr. Abnormal pressure-diuresis-natriuresis response in spontaneous hypertensive rats. Am J Physiol 1985; 248:F199-F205.
5. Griffin KA, Bidani AK. Hypertensive renal damage: insights from animal models and clinical relevance. Curr Hypertens Res 2004; 6:145-153.
6. Levey AS. Nondiabetic kidney disease. N Engl J Med 2002; 347:1505-1511.
7. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau J-L, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular eents, and hospitalization. N Engl J Med 2004; 351:1296-1305.
9. Norris K, Vaughn C. The role of renin-angiotensin-aldosterone system in chronic kidney disease. Expert Rev Cardiovasc Ther 2003; 1:51-63.
10. Mayer G. ACE genotype and ACE inhibitor response in kidney disease: a perspective. Am J Kidney Dis 2002; 40:227-235.
11. Michel MC, Bohner H, Köster J, Schäfers RF, Heemann U. Safety of telmisartan in patients with arterial hypertension: an open-label, observational study. Drug Safety 2004; 27:334-335.
12. Hata A. Role of angiotensinogen in the genetics of essential hypertension. Life Sci 1995; 57:2385-2395.
13. Niu T, Chen X, Xu X. Angiotensin converting enzyme gene insertion/ deletion polymorphism and cardiovascular disease. Therapeutic implications. Drugs 2002; 62:977-993.
14. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E. A poylmorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 1997; 15:1385-1388.
15. Davies E, Kenyon CJ. CYP11B2 polymorphisms and cardiovascular risk factors. J Hypertens 2003; 21:1249-1253.
16. Koopmans RP, Insel PA, Michel MC. Pharmacogenetics of hypertension treatment: a structured review. Pharmacogenetics 2003; 13:705-713.
17. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43:384-388.
18. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin-I-converting enzyme gene. Diabetes 1994; 43:690-695.
19. Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR, et al. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin Nephrol 1999; 51:133-140.
20. Solini A, la Vestra M, Saller A, Nosadini R, Crepaldi G, Fioretto P. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002; 51:251-255.
21. Gohda T, Makita Y, Shike T, Kobayashi M, Funabiki K, Haneda M, et al. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. Clin Nephrol 2001; 56:475-480.
22. Jacobsen P, Tarnow L, Carstensen B, Hovind P, Poirier O, Parving HH. Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14:2843-2850.
23. van Essen GG, Rensma PL, deZeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ, et al. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996; 347:94-95.
24. Jacobsen P, Rossing K, Rossing P, Tarnow L, Mallet C, Poirier O, et al. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy. Kidney Int 1998; 53:1002-1006.
25. Broekroelofs J, Stegeman CA, Navis G, Tegzess AM, de Zeeuw J, de Jong P. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism? J Am Soc Nephrol 1998; 9:2075-2081.
26. Viklicky O, Hubacek JA, Pitha J, Teplan V, Heemann UW, Lacha J, et al. ACE gene polymorphism and long-term renal graft function. Clin Biochem 2001; 34:87-90.
27. Abdi R, Huong TTB, Zee R, Brenner BM, Milford EL. Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation 2001; 72:726-729.
28. Akcay A, Sezer S, Ozdemir FN, Arat Z, Atac FB, Verdi H, et al. Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation 2004; 78:892-898.
29. Baboolal K, Ravine D, Daniels J, Williams N, Holmans P, Coles GA, et al. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in adult polycystic kidney disease. Kidney Int 1997; 52:607-613.
30. Perez-Oller L, Torra R, Badenas C, Mila M, Darnell A. Influence of the ACE gene polymorphism in the progression or renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1999; 34:273-278.
31. van Dijk MA, Peters DJM, Breuning MH, Chang PC. The angiotensin- converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1999; 10: 1916-1920.
32. Konoshita T, Miyagi K, Onoe T, Katano K, Mutoh H, Nomura H, et al. Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. Am J Kidney Dis 2001; 37:113-118.
33. van Dijk MA, Breuning MH, Peters DJM, Chang PC. The ACE insertion/ deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2000; 15:836-839.
34. Lee K-B, Kim UK, Lee CC. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease. J Korean Med Sci 2000; 15:431-435.
35. Saggar-Malik AK, Afzal AR, Swissman JS, Bland M, Sagnella GA, Eastwood JB, et al. Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease. Genet Test 2000; 4:299-303.
36. Schiavello T, Burke V, Bogdanova N, Jasik P, Melsom S, Boudville N, et al. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2001; 16:2323-2327.
37. Ecder T, McFann KK, Raynolds MV, Schrier RW. No effect of angiotensin-converting enzyme gene polymorphisms on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Am J Nephrol 2003; 23:466-470.
38. Merta M, Reiterova J, Stekrova J, Rysava R, Rihova Z, Tesar V, et al. Influence of the α-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease. Kidney Blood Press Res 2003; 26:42-49.
39. Persu A, El-Khattabi O, Messiaen T, Pirson Y, Chauveau D, Devuyst O. Influence of ACE (I/D) and G460W polymorphism of α-adducin in autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation 2003; 18:2032-2038.
40. Asano T, Tatsuma N, Yoshida J, Ohashi R, Ambo K, Tsuchiya M, et al. Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy. Clin Nephrol 1999;51:335-340.
41. Han SY, Kwon YJ, Jo SK, Shin JH, Cha DR, Cho WY, et al. ACE gene polymorphisms and renal responsiveness to ACE inhibitors in IgA nephropathy patients. Korean J Intern Med 2000; 15:13-18.
42. Syrjanen J, Huang XH, Mustonen J, Koivula T, Lehtimaki T, Pasternack A. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy. Nephron 2000; 86:115-121.
43. Maruyama K, Yoshida M, Nishio H, Shirakawa T, Kawamura T, Tanaka R, et al. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001; 16:350-355.
44. Lau YK, Woo KT, Choong HL, Zhao Y, Tana HB, Chong SM, et al. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progresion to end-stage renal failure among Chinese in Singapore. Nephron Physiol 2004; 97:1-8.
45. Samuelsson O, Attman P-O, Larsson R, Mulec H, Rymo L, Weiss L, et al. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. Nephrol Dial Transplant 2000; 15:481-486.
46. Gumprecht J, Zychma MJ, Grzeszczak W, Zukowska-Szezechowska E. Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. Kidney Int 2000; 58:513-519.
47. Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P. Genetic polymorphisms on the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 2001; 60:46-54.
48. Ortiz MA, de Prado A, Donate T, Gallart L, Claramunt H, Hernandez M, et al. Angiotensin-converting enzyme polymorphism gene and evoluation of nephropathy to end-stage renal disease. Nephrology 2003; 8: 171-176.
49. Pel Y, Scholey J, Thai K, Suzuki M, Cattran D. Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in Caucasian patients. J Clin Invest 1997; 100:814-820.
50. Schena FP, D'Altri C, Cerullo G, Manno C, Gesualdo L. ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis. Kidney Int 2001; 60:732-740.
51. Lau YK, Woo KT, Choong HL, Zhao Y, Tan HB, Cheung W, et al. ACE gene polymorphism and disease progression of IgA nephropathy in Asians in Singapore. Nephron 2002; 91:499-503.
52. Delos Santos NM, Ault BH, Gharavi AG, Kritchevsky SB, Quasney MW, Jackson EC, et al. Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol 2002; 17:496-502.
53. Narita I, Goto S, Saito N, Song J, Ajiro J, Sato F, et al. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Hypertension 2003; 42:304-309.
54. Aucella F, Vigilante M, Margaglione M, Grandone E, del Popolo A, Forcella M, et al. Polymorphism of the angiotensin-converting enzyme in end-stage renal failure patients. Nephron 2000; 85:54-59.
55. Coll E, Campos B, Gonzalez-Nunez D, Botey A, Poch E. Association between A1166C polymorphism of the angiotensin II receptor type 1 and progression of chronic renal insufficiency. J Nephrol 2003; 16:357-364.
56. Pernod G, Bosson J-L, Golshayan D, Barro C, Alloatti S, Turc-Baron C, et al. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patientsq. J Nephrol 2004; 17:66-75.
57. Kario K, Kanai N, Nishiuma S, Fujii T, Saito K, Matsuo T, et al. Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb Vascul Biol 1997; 17:252-256.
58. Narita I, Goto S, Saito N, Song J, Omori K, Kondo D, et al. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. Kidney Int 2003; 64:1050-1058.
59. Fabris B, Bortoletto M, Candido R, Barbone F, Gattin MR, Calci M, et al. Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension. J Hypertens 2005; 23:309-316.
60. Castellano M, Glorioso N, Cusi D, Sarzani R, Fabris B, Opocher G, et al. Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER project. J Hypertens 2003; 21:1853-1860.
61. Siani A, Russo P, Cappuccio FP, Iacone R, Venezia A, Russo O, et al. Combination of renin-angiotensin system polymorphisms is associated with altered renal sodium handling and hypertension. Hypertension 2004; 43:598-602.